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an epidemiologic questionnaire and measure CYP1A activity as a 
putative biomarker of chronic exposure to dioxins.
Patients (or Materials) and Methods: Volunteers living in Melun area 
for at least 5 years (between 1974 and 2002) were included in the 
study. A questionnaire was designed to assess source and length of 
exposure, risk and confounding factors, and environmental sources 
of variability in CYP1A activity. The following items were system-
atically assessed: place of habitation, place and type of work, other 
sources of pollution, food questionnaire, smoking, caffeinated drinks 
and alcohol consumption, and medications (CYP1A inhibitors/induc-
ers). They had a full medical history and physical examination with 
a special focus on skin lesions. CYP1A activity was assessed 2 hours 
after the ingestion of a drink containing caffeine through measure-
ment of the ratio (MR) of 17X/137X by liquid chromatography mass 
spectrometry. CYP1A activities were compared with the phenotypes 
of healthy volunteers and to the acute dioxin intoxication of Victor 
Yushchenko described by Sorg et al. (Lancet 2009; 374:1179-85.)
Results: Forty-eight volunteers (age, 11–78) were included in the 
study (25 men, 23 women). A high frequency of dysthyroidism and 
cancer was noticed in the population. Eleven had a history of thy-
roid disease (23%) and 7 (14.5%) had a cancer. Skin lesions were 
described in 13 patients (27%). Mean CYP1A activity of the exposed 
population was comparable to the healthy volunteers (17X/137X 
MR of 0.250 SD 0.08 and 0.273 SD 0.12, respectively). However, 8 
exposed volunteers (16%) had a 17X/137X MR above 0.4, indicating 
that CYP1A is induced (maximal 17X/137X MR of 0.649). CYP1A 
activity was not correlated with the presence of thyroid disease, can-
cer, or skin lesions. After acute dioxin intoxication, CYP1A was more 
strongly induced (maximal 17X/137X MR of 1.9). Induction was still 
persistent 2 years after acute exposure.
Conclusion: A high frequency of dysthyroidism (23%) and cancer 
(14.5%) was noticed in a sample population of Melun area exposed 
chronically to dioxins from a waste incinerator. CYP1A was induced 
in 16% of the population but without significant association with 
thyroid disease, cancer, or skin lesions. After acute dioxin intoxica-
tion, the magnitude of CYP1A induction was 3- to 6-fold higher.
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Introduction: Although accidental poisoning with atypical antipsy-
chotics in children is 1 of the most important causes of morbidity 
after accidental ingestion of medications, the number of studies that 
have assessed the effects of acute exposure to this class of drugs is 
very limited. The aim of this study was to achieve a better char-
acterization of the acute toxicity profile in young children of the 
common atypical antipsychotics clozapine, olanzapine, quetiapine, 
and risperidone.
Patients (or Materials) and Methods: Multicenter retrospective anal-
ysis of cases with atypical antipsychotics intoxication in children 
< 6 years, reported by physicians to German, Austrian, and Swiss 
Poisons Centres between January 1, 2001, and December 31, 2009.
Results: A total of 106 cases of intoxication (31 clozapine, 29 olan-
zapine, 12 quetiapine, and 34 risperidone) were analyzed. Mean age 
was 2.6 years (range, 0.8–5.5). There were 52 (49%) females, 43 
(40.6%) males, and in 11 (10.4%) cases gender was not reported. 
No correlation between age and number of ingested pills was found 
(Spearman correlation coefficient, 0.16). Concerning the number of 
ingested pills, there was no significant difference between males and 
females (Wilcoxon test, P = 0.39). Overall toxicity was rated as severe 
in 2 (1.9%), moderate in 28 (26.4%), and minor in 47 (44.3%) cases 
according to the Poisoning Severity Score. Twenty-eight (26.4%) 
cases were asymptomatic. No fatalities were recorded. Neurological 
and cardiovascular symptoms were predominating. Minor reduc-
tion in vigilance (Glasgow Coma Scale score > 9) (62.3%) was the 
most frequently reported symptom, followed by miosis (12.3%) and 
mild tachycardia (10.4%). Extrapyramidal motor symptoms were 
observed in 1 case (0.9%) after ingestion of 2 mg (0.1 mg/kg) of risp-
eridone. Electrocardiography was performed in 32 (30.2%) children: 
3 (2.8%) showed extrasystoles, and in 1 (0.9%) case a prolonged 
QTc interval (468 ms) was recorded after the ingestion of 150 mg 
(13.6 mg/kg) of quetiapine. For clozapine, the lowest dose causing 
objective symptoms or signs was 0.8 mg/kg, resulting in aggressive-
ness, ataxia, dysarthria, and somnolence; for olanzapine, 0.4 mg/
kg resulting in ataxia and somnolence; for quetiapine, 3.1 mg/kg 
resulting in ataxia and somnolence; and for risperidone, 0.05 mg/kg 
resulting in somnolence and mild tachycardia. In most cases, surveil-
lance and supportive care were sufficient to achieve a good outcome, 
and all children made a full recovery.
Conclusion: Most children poisoned with the atypical antipsychotics 
clozapine, olanzapine, quetiapine, and risperidone had a benign clini-
cal course without sequelae. Extrapyramidal side effects were rare, 
and the only case reported was caused by risperidone. Symptomatic 
patients should be monitored for central nervous system depression, 
and an electrocardiogram should be obtained.
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Introduction: Oranophosphorus compounds are widely used in 
industry, agriculture, and for public health purposes. The aim of 
this work was to study the effect of dimethoate on fertility in adult 
male rats and the possible underlying mechanism of action.
Patients (or Materials) and Methods: The study was conducted on 
healthy, sexually mature male Wistar albino rats weighing between 
250 and 300 g. Animals were assigned randomly into 4 groups, each 
of 6 rats as follows: Group 1, control, orally administered with 1 mL 
of corn oil. Groups 2, 3, and 4 received dimethoate at a dose equiva-
lent to 7, 10.5, and 21 mg/kg body weight, respectively. Commercial 
formulation of dimethoate was used. Radioimmunoassay (RIA) kits 
for determination of testosterone, lutenizing hormone (LH), follicle-
stimulating hormone (FSH), and prolactin hormone. For total cho-
lesterol determination, available kit was used. Fertility test: Each 
male was allowed to undergo mating with 2 females (3–4 months 
old) of proven fertility during the last 10 days of the experiment. 
Serum and organ collections for determination of acetylcholinesterase 
activity and for histopathologic evaluations using light and electron 
microscopic study.
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Results: A significant increase (P < 0.05) in feed consumption, body 
weight gain, relative weights of testis and epididymis and intratesticu-
lar cholesterol level, follicle stimulating hormone (FSH), luteinizing 
hormone (LH), and prolactin was found in rats received dimethoate. 
On the other side, a significant decrease (P < 0.05) in absolute weight 
of testes and epididymis, serum cholesterol and testosterone levels, 
serum acetylcholine esterase (AChE) activity ,total sperm count, 
motility and fertility index was observed compared with the control 
group. Histopathologic results also indicated enlargement of inter-
stitial space, inhibition of spermatogenesis, and variable degrees of 
degenerative changes in the seminiferous tubules up to total cellular 
destruction.
Conclusion: Our results proved that dimethoate, could act as neu-
roendocrine disruptor via inhibition of AChE activity and increase 
of acetylcholine level in brain. This effect might be linked to the 
suppression of the brain’s release of hormones that stimulate the 
gonadotrophic hormones (LH and FSH). So we have to be aware 
that dimethoate has detrimental effects on the male rat reproductive 
system.
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Introduction: The art of herbal healing has very deep roots in 
Bangladeshi culture and folklore. Unani medicines serve as a major 
source of primary health care for Bangladeshi people. The reasons for 
their use range from easy access, affordability, beliefs in traditional 
systems, and long-term safety. Unani medicines have been used to 
treat individuals infected with human immunodeficiency virus (HIV) 
and therefore need scientific validation, a view supported by the herb-
alists.
Patients (or Materials) and Methods: The studies aimed to evaluates 
the in vitro cytotoxicity, immune-modulatory, and anti-HIV activi-
ties of traditional multiple herbal preparations from the herbalists. 
Triphola, Mohasudarshan, Doshomula, Sarasvati, and Hingoshtak 
medicines were supplied by the herbalists.
Results: Changes in adenosine triphosphate and glutathione over 36 
hours were measured using luminometry. Changes in 13 cytokines 
were assayed using an enzyme-linked immunosorbent assay–based 
absorbance assay. Protective effects against HIV killing of metal-
lothionein-IV cells were tested using the cell proliferation kit assay, 
and antiviral activities was measured using an HIV-1 viral load 
assay. Cyclosporine and azidothymidine were used as positive con-
trols. Mohasudarshan, Doshomula, and Sarasvati induced a dose-
dependent toxicity on treated peripheral blood mononuclear cells by 
reducing adenosine triphosphate, and glutathione at high doses (P < 
0.001). These remedial preparations, along with Triphola, showed 
immunomodulatory activities by significantly (P < 0.001) chang-
ing the secretion of pro-inflammatory cytokines. Hingoshtak stimu-
lated the levels of adenosine triphosphate, and glutathione in treated 
peripheral blood mononuclear cells at all doses however this remedial 
did not show any immunomodulatory activities on cytokine secretion 
when compared with control cells. Doshomula, Mohasudarshan, and 
Triphola showed promising anti-HIV activities relative to azidothy-
midine (P < 0.01).
Conclusion: The studies have exposed that some of these traditional 
remedial preparations have at least 1 or all the properties of immu-
nostimulation, immunomodulation otherwise antiretroviral effects. 
Proper scientific studies conducted on these preparations may lead to 
discovery of more effective drugs than in use at present.
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Introduction: Leptospirosis has emerged as a globally spread infec-
tious disease that is caused by spirochete bacteria of the genus 
Leptospira. Xanthones from pericarp of Garcinia mangostana and 
their analogs widely used as medicinal agents against several infec-
tious diseases were examined for inhibitory activity and investigated 
for synergistic effects with antibiotics against Leptospira spp.
Patients (or Materials) and Methods: The minimal inhibitory con-
centrations (MIC) of 5 purified xanthones and 8 xanthone analogs 
were determined against 1 nonpathogenic L biflexa serovar Patoc 
and four pathogenic L. interrogans serovars Bataviae, Autumnalis, 
Javanica, and Saigon by using broth microdilution test. The synergis-
tic effects with penicillin G or ampicillin were evaluated by calculat-
ing the fractional inhibitory concentration (FIC) index.
Results: The 2 xanthones from mangosteen, γ -mangostin and garci-
none C, and the 2 xanthone analogs, 1,3,8-trihydroxyxanthone and 
1,3-dihydroxythioxanthone, showed the highest antileptospiral activ-
ities with the MIC varying from 100 to ≥ 800 µg/mL. Combinations 
of γ -mangostin with penicillin G and 1,3,8-trihydroxyxanthone with 
ampicillin generated synergistic effects at the FIC index of 0.05 to 
0.75 and 0.51 to 0.75, respectively. However, antagonistic activity 
against L interrogans serovar Saigon was observed when combining 
γ -mangostin with penicillin G.
Conclusion: The results demonstrated that the xanthones from G 
magostana and hydroxyxanthone analog inhibited growth of lepto-
spires and there were synergistic effects between these xanthones and 
antibiotics, which could enhance the efficacy of both drugs for the 
treatment of leptospirosis.
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Introduction: Objective: To compare the pharmaceutical quality 
of 7 generic levodopa/benserazide combination products marketed 
in Germany with the original product (Madopar® / Prolopa®). 
Madopar® / Prolopa®is a combination of levodopa (L-Dopa), the 
precursor of dopamine (DA), and benserazide, a dopamine decarbox-
ylase inhibitor (DDCI). It is indicated in the treatmentof Parkinson’s 
disease, dopamine-responsive dystonia, and restless legs syndrome.
Patients (or Materials) and Methods: Madopar®/Prolopa®125 
tablets and capsules were used as reference materials. The generic 
products tested (all 100 mg/25 mg formulations) included 4 tablet 
formulations (ie, Levodopa/Benserazid beta [Betapharm], Levodopa/
Benserazid-CT [CT Arzneimittel], dopadura B [Mylan dura], and 
Levodopa/Benserazid ratiopharm [ratiopharm]) and 3 capsulated 
